Company / Current Liabilities per Share
ENANTA PHARMACEUTICALS INC Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.29
FY2025
5-year range
$1.47 / $3.02
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.42 in FY2016 to $3.02 in FY2023.
Based on SEC 10-K filings.
2.29 in FY2025 with a 5-year CAGR of +13.3%.
Improved from $3.02 to $2.29 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 16.1% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.29 | -16.1% |
| FY2024 | $2.73 | -9.5% |
| FY2023 | $3.02 | +104.9% |
| FY2022 | $1.47 | -18.2% |
| FY2021 | $1.80 | +46.9% |
| FY2020 | $1.23 | +5.2% |
| FY2019 | $1.17 | +39.1% |
| FY2018 | $0.84 | -24.0% |
| FY2017 | $1.10 | +161.5% |
| FY2016 | $0.42 | +16.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026